Medford, MA, United States of America

Melek Nihan Ucisik

This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: Baylor College of Medicine, Foghorn Therapeutics Inc.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Melek Nihan Ucisik. Retrieved from https://idiyas.com/inventor/melek-nihan-ucisik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 6.9

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Melek Nihan Ucisik

Introduction

Melek Nihan Ucisik is a notable inventor based in Medford, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address complex medical disorders.

Latest Patents

Ucisik holds 1 patent for his work titled "Compounds and uses thereof." This patent features compounds of Formula I, or pharmaceutically acceptable salts thereof, and formulations containing the same. The methods disclosed in this patent focus on treating BAF complex-related disorders, such as cancer.

Career Highlights

Ucisik is currently associated with Foghorn Therapeutics Inc., where he continues to innovate and contribute to the advancement of medical science. His work is pivotal in developing new therapeutic strategies for challenging health conditions.

Collaborations

Ucisik collaborates with esteemed colleagues, including Shawn E R Schiller and Solymar Negretti, to further enhance the impact of his research and inventions.

Conclusion

Melek Nihan Ucisik's innovative work in pharmaceuticals exemplifies the vital role of inventors in advancing medical treatments. His contributions are essential in the ongoing fight against complex disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…